Clinical Trial Update: Study to Evaluate the Pharmacokinetics and Pharmacodynamics of AZD4604 Given Via the Turbuhaler® Device in Adults With Mild Asthma. [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic and pharmacodynamic study of AZD4604 delivered via Turbuhaler in adults with mild asthma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD4604

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 1 | Status: COMPLETED